EX-99.1 2 v164085_ex99-1.htm
 

Contact:                                Mark Murphy, Chief Executive Officer
(949) 769-3200

For Immediate Release

PRO-DEX, INC. ANNOUNCES FISCAL FIRST QUARTER 2010 PROFIT,
UPDATE ON BUSINESS DEVELOPMENT ACTIVITIES,
AND RENEWAL OF BANKING AGREEMENT

Company reports first quarter sales of $5.6 million
and earnings per share of $0.02 per share.


IRVINE, CA, October 29, 2009 - PRO-DEX, INC. (NasdaqCM: PDEX) today announced its financial results for the fiscal first quarter ending September 30, 2009.  In addition, Pro-Dex announced that its existing credit agreement with Wells Fargo has been renewed, a new marketing director has been hired, a product development agreement was signed with a new customer, and initial shipments have been made of a newly developed product.

Sales for the first quarter ended September 30, 2009 remained stable at $5.6 million compared to $5.7 million for the previous year’s first quarter, as increases in medical device and motor shipments compensated for continued sluggish motion control sales.  Net income for the fourth quarter was $183,000 or $0.02 per share compared to a net loss of $118,000 or ($0.01) per share for the previous year’s first quarter.

Mark Murphy, the Company’s President and Chief Executive Officer, commented, “In looking at the comparison quarters, we can see the effect of our tuning efforts last year.  In the first quarter of fiscal year 2009, we shipped $5.7 million and lost $0.01 per share, and in this first quarter of fiscal year 2010, we shipped $5.6 million and made $0.02 per share.  In addition to these P&L improvements, we shipped the first 50 units of a new arthroscopic surgical hand-piece during fiscal Q1 2010.  We currently have purchase orders in our backlog totaling $1.4 million for this product with scheduled ship dates through July, 2010.”

Commenting further on the Company’s top line, Mr. Murphy continued, “We’re beginning to see some signs of improvement in our motion control business as those sales have climbed back to nearly half of the sales levels we experienced during each of the five quarters ending December 31, 2008.  Our total company backlog is currently at $9.3 million, up from $8.1 million at September 30, 2009.  We are also pleased to announce the signing of a new development agreement.  The product is for small joint surgery and will include a consumable element that Pro-Dex will provide in addition to the base capital equipment.  The initial Purchase Order is for $150,000, and our annual sales of the related disposables could increase significantly if the product is successful, although there can be no assurance of the product’s design success or acceptance by the customer or the market-place. The development and regulatory testing schedule, assuming successful design and customer acceptance, targets us making initial shipments in the first quarter of next fiscal year.

Gross profit for the quarter ended September 30, 2009 increased to $1.9 million, a 33% gross profit margin, compared to gross profit of $1.8 million or 31% gross profit margin in last year’s first quarter.

Operating expenses for the first quarter decreased by 14% to $1.6 million, compared to $1.9 million in the first quarter 2009.  The continued decrease in spending was attributable to structurally lower costs, primarily decreased labor expenses and more efficient marketing spending, resulting from our FY2009 cost-reduction efforts.

Mr. Murphy continued, “This quarter’s gross profit margin is an accomplishment in light of our lower motion control sales mix, which typically enhances our margins.  Increased product reliability is a major contributor to our improved medical device margins.  In light of the current economic environment, we are encouraged by a second consecutive quarter of profit and cash generation.  To ensure that we identify every possible opportunity for growth, we have hired a new Director of Marketing who joins us with substantial experience in strategic marketing and top line growth.  We look forward to benefitting from this newly created position.”

 
 

 



During the first quarter of fiscal year 2010, we continued to strengthen our balance sheet, generating an additional $409,000 of operating cash, improving our trailing 12 months operating cash from $1.7 million to $2.6 million. At September 30, 2009, we had cash and cash equivalents of $1,378,000 compared to cash and cash equivalents of $1,124,000 as of June 30, 2009. There continued to be nothing borrowed under the terms of the Company’s revolving credit line.  The Company’s net debt (total debt less cash) was $1.8 million at September 30, 2009, down from $2.2 million at June 30, 2009 and down from $4.1 million at September 30, 2008.

On October 27, 2009, we renewed our financing agreement with Wells Fargo through November 1, 2010.  Except for the introduction of a 1.5% unused line fee, the terms and conditions of the agreement remain the same, with the current $1.6 million tenant improvement term loan continuing to amortize over four years and up to $1 million available on our revolving line of credit.


Teleconference Information:

Investors and all others are invited to listen to a conference call discussing the first fiscal quarter 2010 results, today at 4:30 p.m. Eastern Time. The call is scheduled to be broadcast live over the Internet and may be accessed by visiting the Company's website at http://www.pro-dex.com or directly at http://www.videonewswire.com/event.asp?id=63527. Mark Murphy, Chief Executive Officer and Jeff Ritchey, Chief Financial Officer, plan to host the call. If you would like to join the call, dial (877) 356-8625 U.S. and (706) 634-9779 International, conference I.D. 38163047. You may identify the call as the Pro-Dex First Quarter Earnings Call. An online archive of the broadcast will be available within two hours of the completion of the call and will be accessible on the Company's website for 365 days. Additionally, a telephone replay will be available 2 hours after the call for 48 hours by dialing (800) 642-1687 U.S. or (706) 645-9291 for international callers, conference I.D. number 38163047.

Pro-Dex, Inc., with operations in Irvine, California, Beaverton, Oregon and Carson City, Nevada, provides power and control products used in medical, aerospace, military, research and industrial applications.  Experience in multi-axis motion control, fractional horsepower motors and rotary drive systems allows us to develop products that require high precision in harsh environments.  Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, commercial and military aircraft, scientific research facilities and high tech manufacturing operations around the world.  For more information, visit the Company’s website at www.pro-dex.com

Statements herein concerning the Company's plans, growth and strategies may include 'forward-looking statements' within the context of the federal securities laws. Statements regarding the Company's future events, developments and future performance, as well as management's expectations, beliefs, plans, estimates or projections relating to the future, are forward-looking statements within the meaning of these laws. The Company's actual results may differ materially from those suggested as a result of various factors. Interested parties should refer to the disclosure concerning the operational and business concerns of the Company set forth in the Company's filings with the Securities and Exchange Commission.
 
(tables follow)

 
 

 


 
PRO-DEX, INC. and SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
 
             
   
9/30/2009 
(Unaudited)
   
6/30/2009 
(Audited)
 
ASSETS
           
Current assets:
           
     Cash and cash equivalents
  $ 1,378,000     $ 1,124,000  
 Accounts receivable, net of allowance for doubtful accounts
               
      of $46,000 in 2010 and $52,000 in 2009
    2,830,000       2,515,000  
     Other Current Receivables
    49,000       16,000  
     Inventories
    3,532,000       3,365,000  
     Prepaid expenses
    146,000       117,000  
     Prepaid income taxes
    117,000       118,000  
         Total current assets
    8,052,000       7,255,000  
                 
Property, plant, equipment and leasehold improvements, net
    5,846,000       5,981,000  
Other assets:
               
     Goodwill
    2,997,000       2,997,000  
     Intangibles - Patents, net
    144,000       147,000  
     Other
    87,000       87,000  
         Total other assets
    3,228,000       3,231,000  
                     
Total assets
  $ 17,126,000     $ 16,467,000  
LIABILITIES AND SHAREHOLDERS' EQUITY
               
Current liabilities:
               
     Accounts payable
    1,402,000       827,000  
     Accrued expenses
    1,354,000       1,394,000  
     Income taxes payable
    54,000       53,000  
     Current Portion of T.I. Loan
    400,000       400,000  
     Current portion of real estate loan
    33,000       33,000  
        Total current liabilities
    3,243,000       2,707,000  
                 
Long-term liabilities:
               
    Notes Payable - T.I. Loan
    1,267,000       1,367,000  
    Real estate loan
    1,519,000       1,528,000  
    Deferred income taxes
    173,000       171,000  
    Deferred rent
    224,000       212,000  
        Total long-term liabilities
    3,183,000       3,278,000  
                     
Total liabilities
    6,426,000       5,985,000  
Commitments and contingencies
               
Shareholders' equity:
               
     Common shares; no par value; 50,000,000 shares authorized;
               
           9,668,671 shares issued and outstanding Sept 30, 2009
               
           9,668,671 shares issued and outstanding June 30, 2009
    16,609,000       16,574,000  
     Accumulated deficit
    (5,909,000 )     (6,092,000 )
                 
      Total shareholders’ equity
    10,700,000       10,482,000  
                     
     Total liabilities and shareholders’ equity
  $ 17,126,000     $ 16,467,000  
 
See notes to condensed consolidated financial statements.

 
 

 

 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Three months ended September 30 (unaudited)
 
             
   
2009
   
2008
 
             
Net sales
  $ 5,633,000     $ 5,656,000  
                 
Cost of sales
    3,759,000       3,902,000  
Gross profit
    1,874,000       1,754,000  
                 
Operating expenses:
               
     Selling expenses
    289,000       344,000  
     General and administrative expenses
    727,000       835,000  
     Research and development costs
    621,000       731,000  
Total operating expenses
    1,637,000       1,910,000  
                 
Income (loss) from operations
    237,000       (156,000 )
                 
Other income (expense):
               
     Royalty income
    1,000       2,000  
     Interest expense
    (51,000 )     (61,000 )
Total
    (50,000 )     (59,000 )
                 
Income (loss) before provision (benefit) for income taxes
    187,000       (215,000 )
                 
Provision (benefit) for income taxes
    4,000       (97,000 )
Net income (loss)
  $ 183,000     $ (118,000 )
                 
Net income (loss) per share:
               
     Basic
  $ 0.02     $ (0.01 )
     Diluted
  $ 0.02     $ (0.01 )
                     
Weighted average shares outstanding - basic
    9,668,671       9,783,407  
Weighted average shares outstanding - diluted
    9,675,437       9,783,407  


 
 

 


PRO-DEX, INC. and SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Three months ended September 30 (unaudited)

             
   
2009
   
2008
 
Cash Flows from Operating Activities:
           
Net income (loss)
  $ 183,000     $ (118,000 )
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation and amortization
    185,000       222,000  
(Recovery) of provision for doubtful accounts
    (6,000 )     (14,000 )
Stock based compensation
    35,000       42,000  
(Decrease) in deferred taxes
    -       (5,000 )
Changes in:
               
(Increase) in accounts receivable
    (343,000 )     (122,000 )
(Increase) Decrease  in inventories
    (167,000 )     461,000  
(Increase) in prepaid expenses
    (29,000 )     (50,000 )
Decrease in other assets
    -       5,000  
Increase (decrease) in accounts payable and accrued expenses
    547,000       (756,000 )
Increase (decrease) in income taxes payable
    4,000       (124,000 )
Net Cash provided (used) by Operating Activities
    409,000       (459,000 )
                 
Cash Flows From Investing Activities:
               
Purchases of equipment and leasehold improvements
    (47,000 )     (144,000 )
                 
Net Cash used in Investing Activities
    (47,000 )     (144,000 )
                 
Cash Flows from Financing Activities:
               
Net borrowing on line of credit
    -       600,000  
Principal payments on term note
    -       (63,000 )
Principal payments on TI Loan
    (100,000 )     -  
Principal payments on mortgage
    (8,000 )     (7,000 )
Stock repurchases
    -       (60,000 )
                 
Net Cash (used) provided by Financing Activities
    (108,000 )     470,000  
                 
Net increase (decrease) in Cash and Cash Equivalents
    254,000       (133,000 )
Cash and Cash Equivalents, beginning of period
    1,124,000       517,000  
                 
Cash and Cash Equivalents, end of period
  $ 1,378,000     $ 384,000  
                 
Supplemental Information
               
Cash payments for interest
  $ 52,000     $ 56,000  
                 
Cash payments for income taxes
  $ -     $ -